Secondary cancer | Sex | Age at TBI | Time to carcinogene sis (year) | Implant procedure | Primary tumor | State | Cause of death | Chronic GVHD | CTx regimen |
---|---|---|---|---|---|---|---|---|---|
Oral cavity carcinoma | F | 17 | 15.2 | allo-BMT | Lymphoma | Alive | - | ALL202-U | |
Esophageal cancer | F | 39 | 12.2 | allo-BMT | ALL | Alive | - | ALL202-O | |
Border malignant ovarian tumor | F | 43 | 11.3 | allo-BMT | ALL | Alive | + | ALL202-O | |
Thyroid papillary carcinoma | F | 27 | 7.8 | allo-PBSCT | Lymphoma | Alive | - | - | |
Both esophageal and gastric cancer | M | 52 | 7.1 | allo-BMT | MDS | Dead | Aspiration pneumonia | + | - |
Head and neck cancer | M | 55 | 3.0 | allo-BMT | AML | Dead | Secondary cancer | + | IDR+AraC/HDAraC |
Gastric cancer | F | 17 | 1.9 | allo-BMT | AML | Dead | Secondary cancer | + | IDR+AraC/HDAraC |
Ureteral cancer | M | 54 | 6.4 | allo-BMT | MDS | Alive | + | - | |
Extragonadal germ cell tumor | M | 48 | 3.0 | allo-BMT | ALL | Dead | Secondary cancer | + | ALL202-O |
Sub-maxillary gland tumor | F | 29 | 1.4 | allo-BMT | Lymphoma | Alive | + | - |